Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

Journal of Cystic Fibrosis

Volumn 15, Issue 2, 2016, Pages 204-212

  Martin, Clémence ^a,b   Hamard, Cécile ^a,b   Kanaan, Reem ^a,b   Boussaud, Véronique ^b,c   Grenet, Dominique ^d   Abély, Michel ^e   Hubert, Dominique ^a,b   Munck, Anne ^f   Lemonnier, Lydie ^g   Burgel, Pierre Régis ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d FOCH HOSPITAL   (France)

^e AMERICAN MEMORIAL HOSPITAL   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g Vaincre la Mucoviscidose   (France)

Author keywords

Cystic fibrosis exacerbation; Hemoptysis; Lung transplantation; Respiratory failure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; BRONCHIOLITIS OBLITERANS; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE REGISTRY; EPILEPTIC STATE; FEMALE; FRANCE; GRAFT FAILURE; GRAFT INFECTION; HEMATOTHORAX; HEMOPTYSIS; HUMAN; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; MEDICAL RECORD; MIDDLE AGED; PATIENT REFERRAL; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SUDDEN INFANT DEATH SYNDROME; SURGICAL MORTALITY; TREATMENT CONTRAINDICATION; YOUNG ADULT; COMPLICATION; EPIDEMIOLOGY; FOLLOW UP; MORTALITY; PROGNOSIS; REGISTER; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDY; STANDARDS; SURVIVAL RATE; TRENDS;

ADULT; CAUSE OF DEATH; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LUNG TRANSPLANTATION; MALE; PROGNOSIS; REFERRAL AND CONSULTATION; REGISTRIES; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84942033456     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.09.002     Document Type: Article

References (30)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
2. Flume P.A., Mogayzel P.J., Robinson K.A., Rosenblatt R.L., Quittell L., Marshall B.C. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010, 182:298-306.
3. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006, 173:475-482.
4. Cohen-Cymberknoh M., Shoseyov D., Kerem E. Managing cystic fibrosis strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011, 183:1463-1471.
5. Thabut G., Christie J.D., Mal H., Fournier M., Brugière O., Leseche G., et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med 2013, 187:1335-1340.
6. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry. 2002 annual data report to the center directors Bethesda, Md: Cystic Fibrosis Foundation 2002.
7. Halliburton C.S., Mannino D.M., Olney R. Cystic fibrosis deaths in the United States from 1979 through 1991. An analysis using multiple-cause mortality data. Arch Pediatr Adolesc Med 1996, 150:1181-1185.
8. Mitchell I., Nakielna E., Tullis E., Adair C. Cystic fibrosis. End-stage care in Canada. Chest 2000, 118:80-84.
9. Zolin A., McKone E.F., van Rens J., et al. ECFSPR annual report 2010 (accessed August 17th 2014). https://wwwecfseu/projects/ecfs-patient-registry/annual-reports.
10. Cystic Fibrosis Canada The Canadian Cystic Fibrosis Registry. 2011 annual report 2013.
11. Cystic Fibrosis Foundation 2012 annual data report. Cystic Fibrosis Foundation Patient Registry 2013, (Bethesda, Maryland).
12. French Cystic Fibrosis Registry Annual data report 2011 (Accessed on August 31th 2014). http://wwwvaincrelamucoorg/ewb_pages/e/english-versionphp.
13. Burgel P.R., Hamard C., Carlier N., Kanaan R., Abely M., Hubert D., et al. Specific causes of mortality in CF patients in France 2007-2010. J Cyst Fibros 2014, 13(Suppl. 2).
14. Burgel P.R., Hamard C., Martin C. Half of CF deaths in France occur without lung transplant. Pediatr Pulmonol 2014, 49:S376. on behalf of the Death in CF French Study Group.
15. Boussaud V., Mal H., Trinquart L., Thabut G., Danner-Boucher I., Dromer C., et al. One-year experience with high-emergency lung transplantation in France. Transplantation 2012, 93:1058-1063.
16. McGarvey L.P., John M., Anderson J.A., Zvarich M., Wise R.A. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007, 62:411-415.
17. McGarvey L.P., Magder S., Burkhart D., Kesten S., Liu D., Manuel R.C., et al. Cause-specific mortality adjudication in the UPLIFT(R) COPD trial: findings and recommendations. Respir Med 2012, 106:515-521.
18. Yusen R.D., Christie J.D., Edwards L.B., Kucheryavaya A.Y., Benden C., Dipchand A.I., et al. The registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report - 2013; focus theme: age. J Heart Lung Transplant 2013, 32:965-978.
19. Dutau H., Vandemoortele T., Laroumagne S., Gomez C., Boussaud V., Cavailles A., et al. A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation: the MDS classification. Eur J Cardiothorac Surg 2014, 45:e33-e38.
20. Jones A.M., Dodd M.E., Govan J.R., Barcus V., Doherty C.J., Morris J., et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004, 59:948-951.
21. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006, 25(7):745-755.
22. Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 2007, 131:1224-1231.
23. Bellis G., Cazes M.H., Parant A., Gaimard M., Travers C., Le Roux E., et al. Cystic fibrosis mortality trends in France. J Cyst Fibros 2007, 6:179-186.
24. Clancy J.P., Jain M. Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med 2012, 186:593-597.
25. Rosenfeld M., Davis R., FitzSimmons S., Pepe M., Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997, 145:794-803.
26. Meachery G., De Soyza A., Nicholson A., Parry G., Hasan A., Tocewicz K., et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 2008, 63:725-731.
27. Egan T.M., Murray S., Bustami R.T., Shearon T.H., McCullough K.P., Edwards L.B., et al. Development of the new lung allocation system in the United States. Am J Transplant 2006, 6:1212-1227.
28. Cystic Fibrosis Foundation Patient Registry Annual data report to the center directors 2013, 80-81.
29. George P.M., Banya W., Pareek N., Bilton D., Cullinan P., Hodson M.E., et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ 2011, 342:d1008.
30. McCarthy C., Dimitrov B.D., Meurling I.J., Gunaratnam C., McElvaney N.G. The CF-ABLE score: a novel clinical prediction rule for prognosis in patients with cystic fibrosis. Chest 2013, 143:1358-1364.